NVDA
NVIDIA Corporation
NVDA's fundamentals are strong and it looks cheap: trading at 21x earnings, about a third of its usual 65x. Analysts expect strong earnings growth.
PDYN
Palladyne AI Corp.
There isn't enough reported data to score PDYN yet.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
PDYN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
PDYN's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | โ |
| Current | 21x | $166 | โ |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
PDYN PE Valuation
PDYN has no meaningful PE right now: it lost money over the past year.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
PDYN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect PDYN's losses to grow, with revenue growing.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over PDYN on earnings quality, reporting a profit while its opponent remains loss making.
PDYN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.82 | +$0.88 |
| Q2 2026 | -$0.66 | +$1.22 |
| Q1 2026 | -$0.59 | +$1.29 |
| Q4 2025 | $0.24 | +$2.95 |
| Q3 2025 | -$1.70 | +$1.17 |
| Q2 2025 | -$1.88 | +$1.85 |
| Q1 2025 | -$1.88 | +$2.77 |
| Q4 2024 | -$2.71 | +$2.50 |
PDYN lost $0.82 per share over the past year, a smaller loss than the year before, but its loss has widened in each of the last three quarters.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over PDYN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over PDYN on profitability, with a higher operating margin.
PDYN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.6M | +895% |
| Q2 2026 | $5.8M | +470% |
| Q1 2026 | $3.5M | +107% |
| Q4 2025 | $1.7M | +118% |
| Q3 2025 | $860K | -1.3% |
| Q2 2025 | $1M | -63% |
| Q1 2025 | $1.7M | -50% |
| Q4 2024 | $761K | +2% |
PDYN's revenue has grown year over year for four quarters in a row: $9M last quarter, up 895% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -156% | +781 points |
| Q2 2026 | -232% | +566 points |
| Q1 2026 | -337% | +68 points |
| Q4 2025 | -561% | +291 points |
| Q3 2025 | -938% | -100 points |
| Q2 2025 | -797% | -584 points |
| Q1 2025 | -405% | -192 points |
| Q4 2024 | -852% | +4115 points |
PDYN's operating margin was โ156% last quarter, up 781 points from the same quarter a year ago, near the top of its range since 2021.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over PDYN on cash generation, producing positive trailing cash flow while its opponent burns cash.
PDYN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.7M | -$2M |
| Q2 2026 | -$11M | -$5.7M |
| Q1 2026 | -$10.3M | -$2.7M |
| Q4 2025 | -$8.7M | -$3.6M |
| Q3 2025 | -$6.7M | -$2.2M |
| Q2 2025 | -$5.3M | +$614K |
| Q1 2025 | -$7.6M | -$311K |
| Q4 2024 | -$5.1M | +$11.1M |
PDYN has burned cash in almost every quarter: โ$39M over the past year, against โ$25M the year before.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
PDYN Net Leverage
PDYN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
PDYN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.1 | Neutral |
| Stochastic | 8.3 | Oversold |
PDYN's weekly RSI is 32 (neutral) and its Stochastic is 8 (oversold).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
PDYN PE vs Technology Sector
PDYN has no meaningful PE right now: it lost money over the past year.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over PDYN on trend strength, trading above more of its moving averages.
PDYN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.10 | 21% below |
| 20 week MA | $5.03 | 36% below |
| 50 week MA | $5.84 | 45% below |
| 100 week MA | $6.82 | 52% below |
| 200 week MA | $4.34 | 25% below |
PDYN is in a downtrend: it's below all five of its weekly moving averages, and 25% below its 200-week average.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over PDYN on returns for 2026, with the stronger performance.
PDYN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $44.0 | $57.1 | +30% |
| 2022 | $57.1 | $3.30 | -94% |
| 2023 | $3.30 | $0.72 | -78% |
| 2024 | $0.72 | $11.8 | +1535% |
| 2025 | $11.8 | $4.50 | -62% |
| 2026 YTD | $4.50 | $3.24 | -28% |
PDYN's yearly returns have swung widely, from +1535% in 2024 to โ94% in 2022. It's down 28% so far in 2026.